Given the uncertainty of the approval of mainland-made vaccines from Sinovac within the absence of sufficient medical information, specialists advising the federal government on its vaccination programme concluded that there received’t be sufficient vaccines to cowl your entire group within the preliminary stage of the inoculation programme.
As such, one of the best ways is to guard essentially the most susceptible first.
It’s prompt that vaccines from western companies BioNTech and AstraZeneca that Hong Kong has secured must be first given to residents and employees of care houses for the aged or disabled, and different high-risk establishments, in response to RTHK reviews.
The second batch ought to go to individuals aged over 60, healthcare employees, and individuals who present important providers. Then the third batch to these chronically unwell.
Well being officers stated the BioNTech product ought to arrive in late February, and the federal government is attempting to see if there’s any room to hurry the method up.
Whereas ready for extra medical trial information from Sinovac, the federal government can also be looking for a fourth supply, however an settlement has not been reached but.
— Contact us at [email protected]